“Given the improved longevity of individuals with SB [spina bifida], transitional care issues (such as health-related independence) are becoming progressively more vital.”
Castillo et al. J Pediatr Rehabil Med. 2017;10(3-4):219-226.
Intermittent catheterization is today a first choice therapy for people with neurogenic or non-neurogenic lower urinary tract dysfunction related to incomplete bladder emptying. In recent years, the evidence for the safety of catheter reuse has been debated.Read More
Urinary tract anomalies are sometimes seen in children, and many of them require active treatment to achieve continence. Vesicoureteral reflux and/or a neurogenic bladder secondary to meningomyelocele (e.g. spina bifida) are two examples that require swift action.
Catheterization is sometimes a suitable solution and new research has studied the need for local anesthetic associated with catheterization. A meta-analysis combined many study results and concluded that the effect of local anesthetic was limited.
Sometimes, catheterization is not possible through the urethra and a continent catheterizable channel is surgically created. Different procedures (e.g. Mitrofanoff) can be used and two new studies look into the complications associated with this kind of surgery. Both studies conclude that surgical procedures should only be used in children who cannot perform urethral catheterization, because surgical revisions and long-term complications are common.
Another, maybe more far-fetched, solution to these children's problems is the use of stem cell therapy. A new review summarizes the available evidence for stem cell therapy and show that the use of bone marrow stem cells has potential in bladder tissue regeneration.Read More
Urinary tract infections (UTIs) are a heavy burden on the healthcare system today. UTIs are also one of the most common complications among people living with a neurogenic bladder, causing significant complications and health hazards. New clinical research investigates the clinical problem and demonstrates that UTIs are still among the leading causes of death in people with a neurogenic bladder.
On average, people with a neurogenic bladder experience 2 UTI events every year, requiring repeated antibiotic treatments. Frequent use of antibiotics is one of the main contributors to the high prevalence of antibiotic-resistant bacteria today, and as a result, UTIs are getting more expensive and more difficult to treat. As a consequence, there is a major focus in clinical research on the search for non-antibiotic prophylactic treatment for UTIs.Read More
Bowel function in children is a common concern, not only for the child but also parents and caregivers. As it is perceived as a measurement of health, deviations from normal bowel function often instigate numerous visits to a primary care provider.
Consequently, bowel dysfunction is one of the most common problems evaluated by pediatricians, pediatric gastroenterologists, and pediatric surgeons. This may be the reason why two recent publications review diagnosis, standard bowel care, and prevention of pediatric constipation.Read More
Heads or tails? It's the same coin, and when treating neurogenic bladder and bowel, it's the patient that is the unifying focus.Read More
Lower urinary tract symptoms are common after nerve damage and a new review summarizes the treatment forms and reasons behind it in patients with Parkinson disease. One of the treatment options available is intermittent catheterization.Read More